Orforglipron (Foundayo)
Orforglipron (Foundayo) is a research reference peptide. Listed for research and educational reference only.
| Also known as | Oral GLP-1 Receptor Agonist |
|---|---|
| Evidence level | FDA Approved |
| Regulatory status | FDA-approved |
| Updated | 2026-10-12 |
For research and educational reference only.